2021: A Unique World Hepatitis Day
COVID-19 & Sports
COVID-19 & Sports
COVID-19 & Sports
Published Work
From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.
​
Visit us at an upcoming conference >
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users
Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study
Overdose events among active drug users successfully treated for HCV: the impact of homelessness.
Glecaprevir/pibrentasvir+sofosbuvir: An optimal retreatment strategy in the setting of HCV NS5A ...
Sofosbuvir and velpatasvir in the treatment of chronic hepatitis C
Vers l'élimination du VHC en BC : une stratégie pour s'attaquer au 'milieu désordonne'
Efficacité du sofosbuvir/velpatasvir et de l'elbasvir/grazoprevir pour le traitement du VHC de génot
Real-World Efficacy of Salvage Therapies for the Treatment of Chronic Hepatitis C Virus Infection...
Suivi à long terme des personnes qui consomment des drogues (PWUD) suite à un traitement VHC réussi
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C
Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject